Featured Research

from universities, journals, and other organizations

How nanotechnology can advance regenerative medicine

Date:
November 3, 2013
Source:
National Institute for Materials Science
Summary:
Nanotechnology may provide new strategies for regenerative medicine, including better tools to improve or restore damaged tissues.

Nanotechnology may provide new strategies for regenerative medicine, including better tools to improve or restore damaged tissues, according to a review paper by Taiwanese researchers.

Published in the journal Science and Technology of Advanced Materials, the paper summarizes the current state of knowledge on nanotechnology with application to stem cell biology. (The term “nanotechnology” refers to the design, construction, generation and use of nanoscale (1-100 nm) structures or materials.)

Stem cells are considered an important potential source for repairing damaged human tissues. Researchers have found that the adhesion, growth, and differentiation of stem cells are likely controlled by their surrounding microenvironment, which contains both chemical and physical cues. These cues include the “nanotopography” of the complex extracellular matrix or architecture that forms a network for human tissues.

In their review paper, Yang-Kao Wang and colleagues describe studies showing how this nanotopography (which includes nanosized pores, grooves, ridges, etc.) plays important roles in the behaviour and fate of stem cells. The authors also discuss the application of nanoparticles to stem cell isolation, tracking and imaging; how to translate nanotechnology from two to three dimensions; and the potential limitations of using nanomaterials in stem cell biology.

The paper concludes that “understanding [the] interactions of nanomaterials with stem cells may provide knowledge applicable to [the development of improved] cell-scaffold combinations in tissue engineering and regenerative medicine.”


Story Source:

The above story is based on materials provided by National Institute for Materials Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. King-Chuen Wu, Ching-Li Tseng, Chi-Chang Wu, Feng-Chen Kao, Yuan-Kun Tu, Edmund C So, Yang-Kao Wang. Nanotechnology in the regulation of stem cell behavior. Science and Technology of Advanced Materials, 2013; 14 (5): 054401 DOI: 10.1088/1468-6996/14/5/054401

Cite This Page:

National Institute for Materials Science. "How nanotechnology can advance regenerative medicine." ScienceDaily. ScienceDaily, 3 November 2013. <www.sciencedaily.com/releases/2013/11/131103135722.htm>.
National Institute for Materials Science. (2013, November 3). How nanotechnology can advance regenerative medicine. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2013/11/131103135722.htm
National Institute for Materials Science. "How nanotechnology can advance regenerative medicine." ScienceDaily. www.sciencedaily.com/releases/2013/11/131103135722.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins